Skip to main content
SLNO logo
SLNO
(NASDAQ)
Soleno Therapeutics, Inc.
$39.49-- (--)
Loading... - Market loading

Soleno Therapeutics (SLNO) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Soleno Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Soleno Therapeutics, Inc. (SLNO) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Mar 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents70.1187.93169.6814.6021.3021.3049.2220.7323.1017.10
Short-Term Investments235.37203.510.000.000.000.000.000.000.980.00
Cash & Short-Term Investments305.47291.44169.6814.6021.3021.3049.2220.7324.0817.10
Accounts Receivable28.210.000.000.000.000.000.000.000.060.00
Inventory15.020.000.000.000.000.000.000.000.000.00
Other Current Assets7.112.451.681.051.121.121.020.410.530.89
Total Current Assets355.81293.89171.3615.6522.4222.4250.2421.1424.6717.99
Non-Current Assets
Property, Plant & Equipment (Net)2.382.980.420.160.450.450.160.440.010.02
Long-Term Investments0.0027.210.000.000.000.000.000.000.000.00
Goodwill0.000.000.000.000.000.000.000.000.000.13
Intangible Assets4.866.818.7510.6912.6412.6414.5816.5318.4720.41
Other Non-Current Assets200.780.080.170.000.040.040.000.060.000.59
Total Non-Current Assets208.0237.089.3310.8513.1313.1314.7417.0318.4821.03
Total Assets563.83330.97180.6926.5035.5535.5564.9838.1743.1539.02
Current Liabilities
Accounts Payable12.448.883.151.783.253.253.492.000.930.63
Short-Term Debt0.730.530.550.160.280.000.140.310.000.00
Accrued Liabilities4.114.566.533.220.003.424.790.000.000.00
Other Current Liabilities48.202.741.560.484.470.324.992.660.941.10
Total Current Liabilities61.3618.7511.517.318.018.018.624.961.881.73
Non-Current Liabilities
Long-Term Debt1.9649.830.130.000.180.180.000.000.000.00
Other Non-Current Liabilities50.3914.8111.558.849.589.5510.8218.2610.8610.47
Total Non-Current Liabilities52.3567.1111.688.849.759.7510.8218.2610.8610.75
Total Liabilities113.7285.8623.1816.1517.7617.7619.4423.2312.7412.49
Stockholders' Equity
Common Stock0.050.050.030.010.080.080.080.050.030.02
Retained Earnings-431.37-452.26-276.41-237.42-213.36-213.36-182.45-157.81-127.03-113.98
Accumulated Other Comprehensive Income0.420.360.000.000.000.000.000.00-0.09-0.07
Additional Paid-in Capital881.02696.97433.89247.76231.07231.07227.91172.71157.41140.50
Shares Outstanding52.2945.7031.688.160.005.320.000.000.000.00
Total Stockholders' Equity450.12245.11157.5110.3517.7917.7945.5514.9530.4126.53
Total Liabilities & Equity563.83330.97180.6926.5035.5535.5564.9838.1743.1539.02

Frequently Asked Questions About Soleno Therapeutics Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is SLNO's debt level?

Review Soleno Therapeutics's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.